Scinovex
review Open AccessTop 1% cited

Green Chemistry Synthesis of Silver Nanoparticles and Their Potential Anticancer Effects

Cancers · 2020 · Vol. 12(4) · pp. 855–855
Zubair Ahmed RatanMohammad Faisal HaidereMd NurunnabiSadi ShahriarA. J. Saleh AhammadYoun Young ShimMartin J. T. ReaneyJae Youl Cho

Abstract

Nanobiotechnology has grown rapidly and become an integral part of modern disease diagnosis and treatment. Biosynthesized silver nanoparticles (AgNPs) are a class of eco-friendly, cost-effective and biocompatible agents that have attracted attention for their possible biomedical and bioengineering applications. Like many other inorganic and organic nanoparticles, such as AuNPs, iron oxide and quantum dots, AgNPs have also been widely studied as components of advanced anticancer agents in order to better manage cancer in the clinic. AgNPs are typically produced by the action of reducing reagents on silver ions. In addition to numerous laboratory-based methods for reduction of silver ions, living organisms and natural products can be effective and superior source for synthesis of AgNPs precursors. Currently, plants, bacteria and fungi can afford biogenic AgNPs precursors with diverse geometries and surface properties. In this review, we summarized the recent progress and achievements in biogenic AgNPs synthesis and their potential uses as anticancer agents.

Nanoparticles: synthesis and applicationsGraphene and Nanomaterials ApplicationsNanoparticle-Based Drug DeliverySilver nanoparticleNanotechnologyNanobiotechnologyChemistryBiocompatible materialNanoparticleMaterials science

Funding

  • National Research Foundation
  • National Research Foundation of Korea
Citations
308
FWCI
13.87
field-weighted impact
References
168
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.